Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 596164, 9 pages
http://dx.doi.org/10.1155/2015/596164
Review Article

Haemophilia A: Pharmacoeconomic Review of Prophylaxis Treatment versus On-Demand

1Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy
2Institute of Hygiene, Catholic University of the Sacred Heart, Largo Agostino Gemelli 8, 00168 Rome, Italy

Received 8 July 2014; Accepted 6 November 2014

Academic Editor: Angelos E. Hatzakis

Copyright © 2015 Brigid Unim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Alessandro Gringeri, Jennifer Doralt, Leonard A. Valentino, Roberto Crea, and Armin J. Reininger, “An innovative outcome-based care and procurement model of hemophilia management,” Expert Review of Pharmacoeconomics & Outcomes Research, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • E. S. Mullins, O. Stasyshyn, M. T. Alvarez-Román, D. Osman, R. Liesner, W. Engl, M. Sharkhawy, and B. E. Abbuehl, “Extended half-life pegylated, full-length recombinant factor VIII for prophylaxis in children with severe haemophilia A,” Haemophilia, vol. 23, no. 2, pp. 238–246, 2016. View at Publisher · View at Google Scholar
  • Mohammad Zaree, Masomeh Sadat Sabzevari, Ayub Ahmadi, Mahboubeh Ramezanzadeh, and Ali Hosseini Bereshneh, “Hemophilia Gene Therapy; Clinical and Molecular Aspects,” Journal of Human Genetics and Genomics, vol. InPress, no. InPress, 2017. View at Publisher · View at Google Scholar
  • A. Coppola, A. D'Ausilio, A. Aiello, S. Amoresano, M. Toumi, P. Mathew, and A. Tagliaferri, “Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy,” Haemophilia, 2017. View at Publisher · View at Google Scholar
  • M. Drummond, N. Houwing, U. Slothuus, and P. Giangrande, “Making economic evaluations more helpful for treatment choices in haemophilia,” Haemophilia, vol. 23, no. 2, pp. e58–e66, 2017. View at Publisher · View at Google Scholar
  • Chiai Nagae, “Prophylaxis in patients with hemophilia,” Japanese Journal of Thrombosis and Hemostasis, vol. 28, no. 4, pp. 460–471, 2017. View at Publisher · View at Google Scholar
  • Brian M Feldman, Georges E Rivard, Paul Babyn, John K M Wu, MacGregor Steele, Man-Chiu Poon, Robert T Card, Sara J Israels, Nicole Laferriere, Kulwant Gill, Anthony K Chan, Manuel Carcao, Robert J Klaassen, Stephanie Cloutier, Victoria E Price, Saunya Dover, and Victor S Blanchette, “Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort,” The Lancet Haematology, 2018. View at Publisher · View at Google Scholar
  • Mehran Karimi, Peyman Eshghi, Mohammad M. Safarpour, Sezaneh Haghpanah, Aidin Meshksar, Zohreh Zahedi, and Behnaz Habibpanah, “Modified Primary Prophylaxis in Previously Untreated Patients With Severe Hemophilia A in Iran,” Journal of Pediatric Hematology/Oncology, vol. 40, no. 3, pp. 188–191, 2018. View at Publisher · View at Google Scholar
  • Hemant Gupta, Ujjal Protim Dutta, and Partha Pratim Sengupta, “The Socioeconomic Dimensions for the Management of Haemophilia in India: An Empirical Study,” Journal of Health Management, vol. 20, no. 1, pp. 38–45, 2018. View at Publisher · View at Google Scholar